Orange Book product · Brand (NDA)
PREVACID NAPRAPAC 250 (COPACKAGED)
LANSOPRAZOLE; NAPROXEN
At a glance
Nov 14, 2003
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 14, 2003
22 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
LANSOPRAZOLE; NAPROXEN
Strength
15MG,N/A;N/A,250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage form
CAPSULE, DELAYED REL PELLETS, TABLET
Route
ORAL
TE code
Not listed
Application
NDA 021507
Product number
002
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
